Reckitt Spends $3.3 Bil. On Boots, Gains Clearasil Anti-Acne Brand
This article was originally published in The Rose Sheet
Executive Summary
Reckitt Benckiser's $3.3 bil. (£1.9 bil.) cash purchase of Boots Healthcare International establishes the company as a significant player in the OTC consumer products market